首页 › 基金 › Clearwater Capital Advisors, LLC › IBRX
Clearwater Capital Advisors, LLC 对 IBRX 的持仓历史
IMMUNITYBIO INC · 医疗保健
Clearwater Capital Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 IBRX(IMMUNITYBIO INC)717,524 股,市值约 US$6.8M,约占其申报组合的 0.49%,在其申报持仓中市值排名第 35 位。 Clearwater Capital Advisors, LLC 最近 13 个申报季度中有 13 个季度披露了 IBRX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Clearwater Capital Advisors, LLC 对 IBRX 的持仓演变
Clearwater Capital Advisors, LLC 于 Q3 2023 首次披露 IBRX 持仓:394,599 股(约 US$667K)。 该持仓在 Q3 2026 达到峰值 717,524 股,市值约 US$6.8M。 在 13 次申报中,Clearwater Capital Advisors, LLC 3 次增持、1 次减持、8 次保持不变。 最近一期申报(Q3 2026)显示持股 717,524 股、市值约 US$6.8M。 持仓曾出现大幅变动:Q4 2024 增持约 75% (随后一个季度股价上涨 18%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 394.60K | $666.87K | 新进 |
| Q4 2023 | 443.30K | $2.23M | 增持 |
| Q1 2024 | 443.30K | $2.38M | 持有 |
| Q2 2024 | 482.55K | $3.05M | 增持 |
| Q3 2024 | 482.55K | $1.80M | 持有 |
| Q4 2024 | 846.42K | $2.17M | 增持 |
| Q1 2025 | 846.42K | $2.55M | 持有 |
| Q2 2025 | 846.42K | $2.23M | 持有 |
| Q3 2025 | 846.42K | $2.08M | 持有 |
| Q4 2025 | 845.08K | $1.67M | 持有 |
| Q1 2026 | 717.52K | $5.50M | 减持 |
| Q2 2026 | 717.52K | $6.28M | 持有 |
| Q3 2026 | 717.52K | $6.77M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IBRX 与 13F 数据
IBRX(IMMUNITYBIO INC)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 IBRX,申报仓位最大的包括:GREAT POINT PARTNERS LLC (US$26.3M), Sound Capital Solutions LLC (US$9.8M), ALLEN HOLDING INC /NY (US$6.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IBRX 的基金
- GREAT POINT PARTNERS LLC 3.00M 股 · $26.27M · Q2 2026
- Sound Capital Solutions LLC 1.12M 股 · $9.81M · Q2 2026
- ALLEN HOLDING INC /NY 687.57K 股 · $6.49M · Q3 2026
- Kercheville Advisors, LLC 613.38K 股 · $5.79M · Q3 2026
- SHEETS SMITH WEALTH MANAGEMENT 512.57K 股 · $4.84M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K 股 · $4.21M · Q3 2026
更多关于 Clearwater Capital Advisors, LLC
常见问题
How long has Clearwater Capital Advisors, LLC held IBRX?
Clearwater Capital Advisors, LLC has disclosed IBRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Clearwater Capital Advisors, LLC's current position in IBRX?
As of Q3 2026, Clearwater Capital Advisors, LLC holds 717.52K shares of IBRX (IMMUNITYBIO INC), valued at $6.77M, representing 0.49% of its reported portfolio and ranking #35.
Has Clearwater Capital Advisors, LLC been buying or selling IBRX?
In the latest 13F filing (Q3 2026), Clearwater Capital Advisors, LLC held unchanged its position in IBRX. The position peaked in Q3 2026 at 717.52K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, Sound Capital Solutions LLC, ALLEN HOLDING INC /NY, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.